KCNQ2/KCNQ3 potassium channel activators (UCB)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameKCNQ2/KCNQ3 potassium channel activators (UCB)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated potassium channel subunit Kv7.2 agonistsPotassium voltage-gated channel subfamily KQT member 3 stimulants
TargetsVoltage-gated potassium channel subunit Kv7.2Potassium voltage-gated channel subfamily KQT member 3
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUcb Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUcb Sa
Active IndicationsN/A
Inactive IndicationsPain

Other Information

ATC CodeN/A
Related LinksN/A